Aschbacher 2006
| Methods | RCT Method of randomisation: not stated Blinding of outcome assessors: stated as 'yes' by the investigator Adverse events: not stated Deaths: not stated Drop‐outs: 4 (1 in treatment group, 3 in control group) ITT: unclear | |
| Participants | Country: Switzerland 23 participants (12 in treatment group, 11 in control group) Not ambulatory at start of study Mean age: 57 to 67 years (control and treatment groups, respectively) Inclusion criteria: ≤ 3 months after stroke, ability to stand or walk 5 metres Exclusion criteria: orthopaedic problems, contractures, NYHA III‐IV | |
| Interventions | 2 arms:
|
|
| Outcomes | Outcomes were recorded at baseline and after 3 weeks and 6 months later Primary outcomes: walking velocity, step length, endurance, walking ability (FAC) Secondary outcomes: isometric knee extension strength, patient acceptance and satisfaction (Visual Analogue Scale) | |
| Notes | Unpublished data | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Method of randomisation not described |
| Allocation concealment (selection bias) | Unclear risk | Not described |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Unclear |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Unclear |